Evaluation of the tolerability of monoclonal antibody therapy for pregnant patients with COVID-19.

Maternal administration of CAS/IMB was safe. Although it was difficult to evaluate the improvement in disease by blood test findings, the fever improved within 24 h, which suggests rapid improvement in patient condition.